Sample Page
Author:
Trethera Corporation
Posted Date:
May 6, 2026
Trethera To Present Optic Neuritis Research at Los Angeles Bioscience Ecosystem Summit 2026
Trethera Corporation
May 6, 2026
Trethera Announces Appointment of M. Andrew (“Drew”) Woodmansee to Board of Directors
Trethera Corporation
April 21, 2026
Trethera Announces Massachusetts General Hospital Clinical Trial Collaboration to Evaluate TRE-515 in ALS Patients
Trethera Corporation
March 31, 2026
Trethera to Highlight Clinical Momentum and Indication Expansion at Biocom Global Partnering & Investor Conference
Trethera Corporation
February 12, 2026
